We recently published a list of 15 Cheapest Stocks Insiders Are Buying In March. In this article, we are going to take a look at where Zomedica Corp. (OTCQB:ZOMDF) stands against other cheapest stocks insiders are buying in March.
After solid gains Monday, the broader market index and blue chip companies traded flat Tuesday, while the NASDAQ Composite rose 0.2%. Monday’s enthusiasm came from hopes of looser U.S. tariffs.
Investors mostly ignored the March consumer confidence data released on Tuesday, which showed a sharp decline in U.S. consumers’ short-term outlook on income, business, and job conditions, reports CNBC.
“Sentiment continues to wane among investors, consumers and businesses as economic concerns and economic policy uncertainty takes its toll,” said Bret Kenwell, U.S. investment analyst at eToro. “Until there’s more certainty on the tariff and macro front, sentiment and confidence remain vulnerable.”
As investors navigate daily market changes, uncertainty remains a persistent factor. Insider trading tends to attract attention during these periods, as purchases of company stock by executives may suggest optimism about the company’s future. However, insider selling doesn’t necessarily signal a lack of confidence—it could simply be for personal financial reasons or to diversify holdings. Many executives use pre-established plans, such as 10b5-1, to maintain transparency. While insider trading can provide useful insights, it’s important to evaluate it alongside a company’s financial stability, broader market trends, and industry dynamics.
What are some of the cheapest stocks insiders have been buying this month so far? To find out, we used Insider Monkey’s insider trading stock screener, focusing only on stocks where at least two insiders had purchased shares in March. From there, we ranked the 10 stocks with the lowest average price per share.
Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds, focusing on insider trading and stock picks from hedge fund investor newsletters and conferences. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
With each stock, we note the average price per share of these purchases and the stock’s market capitalization.
A veterinarian in a veterinary clinic examining a companion animal.
Zomedica Corp. (OTCQB:ZOMDF)
Market Capitalization: $66.64 million
Zomedica, a veterinary health company, ranks first among the 15 cheapest stocks insiders are buying in March. The Ann Arbor, Michigan-headquartered company develops diagnostic and therapeutic products for companion animals. Its offerings include diagnostic platforms like TRUFORMA and TRUVIEW, as well as therapeutic products such as PulseVet and Assisi Loop devices for pain and inflammation treatment. The company also collaborates with Celsee, Inc. and Seraph Biosciences, Inc. to develop advanced diagnostic and pathogen detection solutions.
For the full year 2024, Zomedica disclosed revenue of $27.3 million, compared to $25.2 million for 2023. Operating expenses were $70.1 million, including a full year of expenses related to Qorvo Biotechnologies, compared to $60.6 million the previous year. Research and development expenses amounted to $7.3 million, compared to $5.8 million for 2023. Net loss was $47.0 million, which compares to a net loss of $34.5 million in 2023.
In March, eight insiders, including the CEO, COO, and CFO, acquired approximately $279,286 worth of Zomedica shares at an average price of $0.07 per share. Currently, the stock trades at $0.068, having declined 43.33% year-to-date and 50.72% over the past 12 months.
According to TipRanks, one Wall Street analyst has rated Zomedica stock as a “Moderate Buy” with a price target of $0.25 per share. The average price target suggests a potential upside of 284.62% from the latest price.
Overall, ZOMDF ranks 1st on our list of cheapest stocks insiders are buying in March. While we acknowledge the potential of ZOMDF our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ZOMDF but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
